SCHEMBL1722571

SCHEMBL1722571

Cn1cc(N)nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16754653 0.97
SCHEMBL434999 0.69
SCHEMBL197556 0.69
SCHEMBL2680263 0.69
SCHEMBL22230154 0.68 PCSK9 (0.43)
SCHEMBL18791140 0.67
SCHEMBL20242115 0.67 KEAP1 (0.31)
SCHEMBL11965055 0.67
SCHEMBL10259340 0.67
SCHEMBL17049132 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746965-A1 BENZIMIDAZOLES AS SIK-ACTIVITY MODULATORS F. Hoffmann-La Roche AG (CH) 2026-05-27 EP disclosed
US-20250032625-A1 HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS Merck Patent KGaA (DE) 2025-01-30 US disclosed
WO-2025017041-A1 BENZIMIDAZOLES AS SIK-ACTIVITY MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2025-01-23 WO disclosed
US-12202826-B2 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway REDX PHARMA PLC (GB) 2025-01-21 US disclosed
EP-4426700-A1 HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS Merck Patent GmbH (DE) 2024-09-11 EP disclosed
US-20240270747-A1 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS GENENTECH, INC. (US) 2024-08-15 US disclosed
EP-3365334-B1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS OTSUKA PHARMA CO LTD (JP) 2024-07-17 EP disclosed
EP-3411069-B1 HUMANIZED ANTI-CD3 ANTIBODIES, CONJUGATES AND USES THEREOF SCRIPPS RESEARCH INST (US) 2024-07-10 EP disclosed
WO-2024110608-A1 PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS NEURALIS (BE) 2024-05-30 WO disclosed
WO-2024086767-A2 GLYCAN CONJUGATE COMPOSITIONS AND METHODS GANNA BIO, INC. (US) 2024-04-25 WO disclosed
WO-2010103438-A1 SUBSTITUTED INDAZOLE AMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS PFIZER INC. (US) 2010-09-16 WO disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed
WO-2010097373-A1 COMPOUNDS FOR USE AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed
US-20100167986-A1 Cholesteryl Ester Transfer Protein Inhibitors MERCK SHARP & DOHME CORP. 2010-07-01 US disclosed
WO-2010057899-A1 CYCLOALKYL AMINO CARBONYL DERIVATIVES AS BRADYKININ-B1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-05-27 WO disclosed
EP-1942904-A2 CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS Merck & Co., Inc. (US) 2008-07-16 EP disclosed
WO-2007041494-A2 CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS MERCK & CO., INC. (US) 2007-04-12 WO disclosed
EP-0950249-A4 HIGH OLEIC ACID ELECTRICAL INSULATION FLUIDS AND DEVICES CONTAINING THE FLUIDS ABB POWER T & D CO (US) 2000-05-03 EP disclosed
EP-0950249-A1 HIGH OLEIC ACID ELECTRICAL INSULATION FLUIDS AND DEVICES CONTAINING THE FLUIDS ABB POWER T &amp; D COMPANY INC. (US) 1999-10-20 EP disclosed
WO-1998031021-A1 HIGH OLEIC ACID ELECTRICAL INSULATION FLUIDS AND DEVICES CONTAINING THE FLUIDS ABB POWER T & D COMPANY INC. (US) 1998-07-16 WO disclosed